 Raf is a proto-oncogene because mutations in this protein have been found in many cancers.The Rho GTPase Vav1, which can be activated by the GEF receptor, has been shown to promote tumor proliferation in pancreatic cancer.GEFs represent possible therapeutic targets as they can potentially play a role in regulating these pathways through their activation of GTPases.